ImGTS for Patients With Behavioral and Psychological Symptoms of Dementia (Phase 2)

NCT ID: NCT06072014

Last Updated: 2023-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-10

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The proposed research project aims to answer the question "Are immersive technology systems effective in the management and treatment of patients with BPSD?". This project is composed of three phases and the current study is the second phase. The phase 2 trial aims to create an immersive technology system for managing the behavioral and psychological symptoms of dementia and determine its clinical effectiveness, safety, usability, and acceptability among patients with mild to moderate Alzheimer's disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dementia Alzheimers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Head-mounted display (HMD)

The HMD system uses a commercially available virtual headset, the Oculus/Meta Quest 2, which allows a user to view a virtual environment in 360 degrees and to interact with the environment using hand-tracking technology (i.e., when a user's hand is projected into the virtual world to be used for interactions and gestures).

Group Type EXPERIMENTAL

Virtual reality

Intervention Type OTHER

A role-playing game with activities based on existing therapy activities (such as orientation therapy, reminiscence therapy, art therapy, and music therapy) that are used to manage behavioral and psychological symptoms of dementia

Semi-cave automatic virtual environment (semi-CAVE)

The semi-CAVE system uses projectors and projector screens to provide a 270-degree view of the virtual environment. These projectors are connected to a powerful workstation (desktop computer), which uses HTC Vive trackers and base stations to track user movements and interactions

Group Type EXPERIMENTAL

Virtual reality

Intervention Type OTHER

A role-playing game with activities based on existing therapy activities (such as orientation therapy, reminiscence therapy, art therapy, and music therapy) that are used to manage behavioral and psychological symptoms of dementia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual reality

A role-playing game with activities based on existing therapy activities (such as orientation therapy, reminiscence therapy, art therapy, and music therapy) that are used to manage behavioral and psychological symptoms of dementia

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 60 years old or older
* Diagnosed with mild to moderate Alzheimer's dementia according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria
* Montreal Cognitive Assessment-Philippines (MOCA-P) score of 10-20 inclusive
* Neuropsychiatric Inventory (NPI-12) score 1-50 inclusive
* Reisberg Scale Stage 4-5 inclusive
* Stable dose of antidepressants for the past 6 weeks
* Stable dose of antipsychotics for the past 4 weeks
* Able to walk unassisted or with minimal assistance, with or without assistive device
* No other explanation for condition based on reasonable clinical diagnostics

Exclusion Criteria

* Have mild cognitive impairment (no dementia)
* Have MOCA-P score less than 10 or more than 20
* Other non-amnestic dementia syndromes
* Have receptive aphasia
* Have significant visual or hearing impairment
* Have an active psychiatric disorder prior to Alzheimer dementia diagnosis
* Had previous episodes of seizures, diagnosis of epilepsy, or intake of antiepileptic or seizure medications
* Have quadriplegia or paralysis of the dominant hand
* Have a history of motion sickness
* Experience claustrophobia
* Have a diagnosis of a terminal illness or a life expectancy of less than one year
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Augmented eXperience E-health Laboratory

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Veeda Michelle M. Anlacan, MD

Role: PRINCIPAL_INVESTIGATOR

University of the Philippines Manila

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of the Philippines College of Allied Medical Professions Immersive Technology Laboratory

Manila, National Capital Region, Philippines

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Philippines

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Roland Dominic G. Jamora, MD, PhD

Role: CONTACT

+639985438062

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Maria Eliza R. Aguila, PhD

Role: primary

+639178212563

References

Explore related publications, articles, or registry entries linked to this study.

Anlacan, V.M.M. et al. (2023). Application Design for a Virtual Reality Therapy Game for Patients with Behavioral and Psychological Symptoms of Dementia. In: Krouska, A., Troussas, C., Caro, J. (eds) Novel & Intelligent Digital Systems: Proceedings of the 2nd International Conference (NiDS 2022). NiDS 2022. Lecture Notes in Networks and Systems, vol 556. Springer, Cham. https://doi.org/10.1007/978-3-031-17601-2_15

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AXEL0003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.